Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2022-07-12 00:00:00 ET · period of report 2022-07-08 · accession 0001209191-22-041947 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-12 | 2022-07-08 | RXRX | Dar Zavain | Dir | J - Other | $0.00 | +2,420 | 20.6K | +13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-07-08 | J | A | 2,420 | $0.00 | 20,565 | D | — | — |